Trial Better: The ERT Blog

TRIAL BETTER

See what we’re up to – and what we have to say – in today’s dynamic market.

What does CNS Endpoint Measurement have in Common with the Fosbury Flop?

Learn how clinical trial sponsors can raise the bar in developing more effective treatments for movement disorders by using high precision wearables and digital biomarkers to reinvent endpoint measurement.

Updated Guidelines for Spirometry Use: Better Results and a Better Patient Experience in Respiratory Trials

Here we share just a few of the highlights of the 2019 ATS/ERS standards and elaborate on how sponsors can implement them in respiratory trials to drive more accurate study results and a better patient experience.

FDA Guidance Overview: Assessing Symptoms in Clinical Trials Aimed to Prevent and Treat COVID-19

Learn the FDA’s position on assessing symptoms in clinical trials of drugs and biologics for the prevention and treatment of COVID-19.

Quantitative Biomarkers in Clinical Research Imaging Trials

Learn how quantitative imaging has the potential to improve statistical power and may reduce reader process time, time-based expenses, and imaging data quality.

How Virtual Trial Technology is Changing the Face of Clinical Research

In this interview, Jim Corrigan explains ERT’s role in delivering the technological advancements that are driving clinical study continuity and how virtual trial technologies will continue to benefit patients, sites, and sponsors well after the pandemic.

Endpoint Adjudication Strategies in Clinical Trial Imaging – Part 2

Here we review different strategies for endpoint adjudication in clinical trials that require medical imaging, with a focus on the regulatory and statistical requirements that can impact a clinical trial’s outcome.

ECG/EKG Advancements in the Era of COVID-19

Learn how patient-administered ECG/EKG testing is enabling sponsors to continue important clinical trials during the pandemic, and after.

Improving Patient Compliance and Retention in Oncology Clinical Trials

Design your oncology trials around patients’ preferences, expectations, and lifestyles to keep them better engaged throughout their clinical trial journey.

Clinical Trial Imaging: Multiple Endpoint and Adjudication Strategies – Part I

This blog reviews approaches to reduce the impact of multiplicity related to multiple endpoints in imaging clinical trials.

COVID-19 and the Industry’s Leap into Virtual Clinical Trials

In this blog, ERT’s President and CEO, Jim Corrigan, shares his thoughts on how COVID-19 has impacted clinical development, how ERT is responding, and what we can expect in a post-pandemic world.

Oncology Trials during the COVID-19 Pandemic: Using Virtual Trial Technology to Keep Patients Safe

Proven virtual trial technologies offer a solution to the many challenges clinical trial sponsors and CROs are facing,. Learn how they can be especially valuable in oncology trials, where limiting patients’ exposure to COVID-19 has become an important objective in the current era of clinical development.